Does thyroid hormone status control hepatic SHBG production and change free testosterone levels?

Thyroid hormone status is a primary regulator of hepatic sex hormone-binding globulin (SHBG) production, creating a direct link between thyroid function and the bioavailability of sex steroids like testosterone.

Hepatic mechanisms of SHBG regulation

Thyroid hormones (TH), specifically triiodothyronine (T3), exert direct transcriptional control over the synthesis of SHBG in the liver.

• Molecular signaling: T3 binds to thyroid hormone receptors (THRα and THRβ) within hepatocytes. These receptors form complexes that bind to thyroid response elements (TREs) in the promoter regions of target genes.
• Transcriptional activation: A key mechanism involves the induction of hepatocyte nuclear factor 4α (HNF4α). T3-stimulated receptors increase the expression of HNF4α, which then binds to the SHBG promoter to transactivate its expression. In human hepatoma cell models (HepG2), T3 treatment significantly induces SHBG mRNA and protein production; this effect is neutralized if HNF4α is silenced.
• Intracellular conversion: The liver expresses deiodinase type 1 (DIO1), which converts the pro-hormone T4 into active T3, amplifying the transcriptional response of the SHBG gene to circulating thyroid levels.

Impact on steroid metabolism and free testosterone

Shifts in thyroid signaling alter the "buffering" capacity of the blood for sex steroids by changing the concentration of SHBG, which has a high affinity for testosterone.

• Hyperthyroid states: Elevated thyroid hormones significantly increase SHBG levels—often by 200% to 400%. Because SHBG binds testosterone tightly, this surge in SHBG increases the fraction of total testosterone that is protein-bound, typically resulting in a lower percentage of free, bioavailable testosterone.
• Hypothyroid states: Conversely, reduced thyroid signaling leads to lower SHBG synthesis. In women with hypothyroidism, the decrease in SHBG results in a higher Free Androgen Index (FAI), meaning a larger proportion of total testosterone remains in the free or unbound state.
• Genetic evidence: Mendelian randomization studies confirm a causal link, showing that genetic variants associated with higher TSH (a marker of lower thyroid function) correlate with lower SHBG and higher free androgen levels.

Bottom line

Thyroid hormones directly control the hepatic production of SHBG via the HNF4α pathway. Consequently, hyperthyroidism generally raises SHBG (decreasing free testosterone), while hypothyroidism lowers SHBG (potentially increasing the free testosterone fraction), making thyroid status a critical determinant of androgen bioavailability.